Presbyterian Children's Care Program has been granted membership to the Children's Oncology Group (COG), allowing pediatric patients access to the most current treatment trials for their cancer.
COG, a National Cancer Institute supported clinical trials group, is the world's largest organization devoted exclusively to pediatric cancer research.
"Through our membership, we will now have access to the latest treatment trials, research and clinical studies." said Dr. John Pederson, medical director of Presbyterian Children's Care Program. "This is a great benefit for our patients in accessing the latest therapies."
The Presbyterian Pediatric Hematology/Oncology Program provides cancer treatment for infants, children, adolescents and young adults with a wide range of congenital and acquired blood disorders and cancers. The skilled pediatric clinical staff works together to continuously improve patient outcomes and maintain an environment of family-centered care.
"Becoming a member is a rigorous process that our Children's Care Program has been working towards for five years," said Dr. Pederson. "This helps our program further elevate the care that we provide by allowing access to the latest research and treatment trials."
COG works with industry partners to develop effective new treatments for children with cancer. COG includes more than 10,000 experts in childhood cancer at more than 200 leading children's hospitals, universities and cancer centers across North America, Australia, New Zealand and Europe.
To help achieve COG membership, Presbyterian Children's Care Program partnered with the University of New Mexico Cancer Center's Dr. Benny Liem, a pediatric radiation oncologist.
The first patient at Presbyterian is expected to be enrolled in therapeutic trials in the spring.